AVRA Medical Robotics, Inc. (OTC: AVMR) PROVIDES UPDATE ON MERGER
CardioVentures holds an indirect controlling interest in an Indian private limited company (“SSI India“). SSI India is engaged in the development, commercialization, manufacturing and sale of medical and surgical robotic systems leveraging patents, trademarks and other intellectual property. It has received full clinical approval from the Indian regulatory bodies and is now able to accept and deliver orders for its Mantra surgical robotic system within
Upon completion of the merger, the Company will change its name to
It empowers doctors and the practice of surgery through the use of software and artificial intelligence.
AVRA concentrates its research and development efforts to meet the rising expectations of patients and practitioners for the accuracy, efficiency and safety offered by robotics, artificial intelligence and proprietary software when combined with proven medical devices and surgical instruments.
For more information visit AVRA’s website at www.avramedical.com.
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “expect”, “assume”, “believe”, “estimate”, “expect”, “will”, “intend”, “may”, “plan”, “project”, “should”, “could”, “seek”, “design”, “potential”, “forecast”, “target”, “goal”, “objective” or the negative of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or AVRA’s future financial performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or performances expressed or implied by these forward-looking statements.
Contact: [email protected]
2022 GlobeNewswire, Inc., source